PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28968471-4	2017	The effects and mechanisms of epirubicin treatment on the expressions of upstream survival signals (e.g., beta-catenin) and downstream MDR transporters (e.g., P-gp) and anti-apoptotic pathways (e.g., Bcl-2) were assessed with or without HuR knockdown (siHuR) or overexpression (overHuR; ectopic HuR or pcDNA3/HA-HuR).	Epirubicin	30-40	catenin beta 1	Homo sapiens	106-118	
32811806-8	2020	Finally, DNER protects BC cells from epirubicin-induced growth inhibition and apoptosis via the Wnt/beta-catenin pathway.	Epirubicin	37-47	catenin beta 1	Homo sapiens	100-112	
28968471-12	2017	Our findings provide insight into the mechanisms by which siHuR potentiated epirubicin-induced cytotoxicity via inhibiting galectin-3/beta-catenin signaling, suppressing MDR transporters and provoking apoptosis.	Epirubicin	76-86	catenin beta 1	Homo sapiens	134-146	
28968471-5	2017	Our results showed that siHuR decreased transcriptional expressions of galectin-3, beta-catenin, cyclin D1, Bcl-2, P-gp, MRP1, and MRP2 in epirubicin-treated colon cancer cells.	Epirubicin	139-149	catenin beta 1	Homo sapiens	83-95	
24303084-10	2013	We show for the first time that the silencing of galectin-3 sensitizes MDR cells to epirubicin by inhibiting ABC transporters and activating the mitochondrial pathway of apoptosis through modulation of the beta-catenin/GSK-3beta pathway in human colon cancer cells.	Epirubicin	84-94	catenin beta 1	Homo sapiens	206-218	
22529978-5	2012	Epirubicin-treated GRP78 knockdown cells resulted in more inactivated Akt pathway members, such as phosphorylated Akt and GSK-3beta, as well as downstream targets of beta-catenin expression.	Epirubicin	0-10	catenin beta 1	Homo sapiens	166-178